Thank you! Your request has been received.
A member of our team will reach out to you shortly,
Oops! Something went wrong while submitting the form.
+
Founded in 2020, Pienomial is redefining how life sciences organizations accelerate and de-risk drug development. Our mission is rooted in the belief that a healthier world is possible through smarter, faster, and more collaborative decision-making.
We empower pharmaceutical, biotech, CROs, and life sciences consulting firms to transform unstructured biomedical data into actionable intelligence—supporting evidence-driven decisions across every phase of the drug lifecycle.
At the heart of Pienomial is Knolens, our proprietary AI-powered intelligence platform. Designed with scientific integrity in mind, Knolens delivers:
Pienomial, 1 Research Court, Suite 450, Rockville, MD 20850
2nd Floor, B Wing, FQQV+G38 Highway Height, Atul Nagar, Warje, Pune, Maharashtra 411058
Pienomial is an AI LifeScience company that transforms how professionals access and analyze data in support of their business goals. Whether you are in Big Pharma or a small biotech; or a service provider to the industry Pienomial can help you in a range of functions in your business.
Knolens is our flagship platform that leverages advanced AI to extract real-time, accurate insights from clinical trials, scientific publications, and other data sources in the life sciences domain.
Knolens, through its AI-driven analysis, helps streamline product development and enhance decision-making—empowering researchers, developers, and strategists in life sciences to stay ahead in a competitive and fast-evolving industry.
Knolens uses a combination of multiple techniques including automated AI pipelines, human verification and domain expertise to ensure high relevance, accuracy and reliability of the data used in the analysis.
Knolens can easily integrate and analyze a wide range of structured and unstructured information including but not limited to PubMed, EMA databases, and scientific journals, financial reports and other data sources. Our customers can also optionally choose to leverage the power of our platform with their internal knowledge bases and data sources.
Yes, the Knolens platform is built for modularity and configurability. Our customers choose to use it in a way that provides them unique benefits specific to their business goals while leveraging the power of a stable, proven platform.
Trusted by global pharma, biotechs, and life sciences leaders
Pienomial exceeded our expectations. Development Strategy Dossier delivers strategic insights across clinical and commercial domains — and we’re excited to expand its use across more teams.
Pienomial has been a trusted partner for over five years. Their intelligent solutions are embedded in our product delivery workflows and remain critical to our operational efficiency.
Knolens has transformed the way we work. Pienomial’s relentless focus on innovation helps us stay ahead in a highly competitive landscape.
With Knolens, what used to take weeks of manual review now takes minutes — and we can trust every result.
